Related Experiment Video
Updated: Jun 30, 2025
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
791
LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal
Zhenchong Li1,2,3, Zuyi Ma4, Shujie Wang5
1Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China.
Biology Direct
|March 20, 2024
Summary
Long non-coding RNA LINC00909 promotes pancreatic cancer stemness and metastasis by inhibiting SMAD4, upregulating pluripotency factors, and activating the MAPK/JNK pathway. This study reveals LINC00909 as a potential therapeutic target for pancreatic cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic cancer stem cells drive tumor growth and metastasis.
- Long non-coding RNAs (lncRNAs) are implicated in Pancreatic Ductal Adenocarcinoma (PDAC) stemness, but mechanisms remain unclear.
- This study investigates the role of LINC00909 in PDAC stemness and metastasis.
Purpose of the Study:
- To explore the function of LINC00909 in regulating pancreatic cancer stemness.
- To elucidate the mechanism by which LINC00909 influences cancer metastasis.
- To identify LINC00909 as a potential therapeutic target in pancreatic cancer.
Main Methods:
- In situ hybridization to assess LINC00909 expression in 80 PDAC tissues.
- RNA sequencing and bioinformatics analysis of PANC-1 cells.
- In vitro and in vivo experiments to evaluate LINC00909's role in stemness and metastasis.
- Investigation of LINC00909 interactions with SMAD4 and pluripotency factors.
Main Results:
- LINC00909 is upregulated in PDAC tissues and correlates with poor prognosis.
- LINC00909 overexpression enhances stemness and metastasis, while knockdown reduces them.
- LINC00909 inhibits SMAD4 post-transcriptionally, upregulating pluripotency factors and activating the MAPK/JNK pathway.
- LINC00909 overexpression accelerates tumor growth and metastasis in mouse models.
Conclusions:
- LINC00909 promotes pancreatic cancer stemness and metastasis by downregulating SMAD4.
- This mechanism involves upregulation of pluripotency factors and activation of the MAPK/JNK pathway.
- LINC00909 represents a potential therapeutic target for pancreatic cancer treatment.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K